Axsome Therapeutics Inc. (AXSM)
NASDAQ: AXSM
· Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.00
-1.10%
After-hours: Aug 15, 2025, 07:57 PM EDT
Axsome Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -246.9M | -278.27M | -287.22M | -310.95M | -308.55M | -296.38M | -239.24M | -201.83M | -184.45M | -158.72M | -187.13M | -159.87M | -149.93M | -140.78M | -130.4M | -125.59M | -113.63M | -99.68M |
Depreciation & Amortization | 7.56M | 7.85M | 7.96M | 7.63M | 7.31M | 6.69M | 6.83M | 7.11M | 7.33M | 7.23M | 5.56M | 3.85M | 2.19M | 1.2M | 1.16M | 909.49K | 615.27K | 343.37K |
Stock-Based Compensation | 91.56M | 88.34M | 85.22M | 82.15M | 75.33M | 69.87M | 62.62M | 54.47M | 48.83M | 43.07M | 37.73M | 32.85M | 29.37M | 24.67M | 20.8M | 20.52M | 17.66M | 16.35M |
Other Working Capital | 6.42M | 39.97M | 30.93M | 16.97M | 46.58M | 16.29M | 34.21M | 33.95M | 43.37M | 46.3M | 41.19M | 27.52M | 5.31M | 3.37M | 679.48K | 1.92M | 2.6M | -3.71M |
Other Non-Cash Items | 30.41M | 44.16M | 70.29M | 103.27M | 65.97M | 70.13M | 53.1M | 12.46M | 11.55M | 3.76M | 3.66M | -564.64K | -683.68K | -96.52K | -104.61K | 234.39K | 368.21K | 618.32K |
Deferred Income Tax | n/a | n/a | n/a | -617K | -617K | n/a | n/a | 617K | 617K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | 1.25M |
Change in Working Capital | -3.27M | 19.61M | 12.8M | 3.42M | 10.54M | -25.57M | -28.39M | -15.12M | 4.63M | 14.98M | 23.67M | 5.95M | -2.76M | 1.34M | 324.79K | 3.99M | 4.84M | -1.28M |
Operating Cash Flow | -120.63M | -118.32M | -128.41M | -132.57M | -167.49M | -192.73M | -145.08M | -142.28M | -111.49M | -89.68M | -116.51M | -117.79M | -121.81M | -113.66M | -108.23M | -99.94M | -88.9M | -82.4M |
Capital Expenditures | 120K | 68K | -30K | -7K | -528K | -609K | -582K | -755.86K | -450.91K | -559.37K | -702.11K | -213.7K | -406.32K | -183.74K | n/a | -327.84K | -84K | -66.56K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -53M | -53M | -53M | -53M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -591K | -578K | -338K | -920K | -680K | -680K | -653K | -53,702.1B | -53,702.1B | -53,702.1B | -53,915.8B | -521.28B | -521.28B | -521.28B | -337.54B | -75.89B | -75.89B | -75.89B |
Investing Cash Flow | -471K | -510K | -270K | -247K | -528K | -609K | -582K | -755.86K | -450.91K | -53.56M | -53.7M | -307.6B | -307.6B | -307.55B | -307.55B | -327.84K | -84K | -66.56K |
Debt Repayment | -1.04M | -1.23M | -990K | -660K | -349K | 29.84M | 85M | 85M | 85M | 100M | 45M | 45M | 45M | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -1.33M | -2.95M | -3.23M | -3.23M | -1.9M | -1.15M | -1.03M | -1.03M | -1.03M | -162.68K | -91.7K | -91.7K | -91.7K | -91.7K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 47.47M | 59.6M | 29.31M | 31.15M | 13.16M | -10.33M | -11.87M | -10.8M | -11.52M | -4.69M | -2.21M | -2.58M | -1.05M | 1.92M | 3.92M | 3.27M | 30.26M | 29.57M |
Financial Cash Flow | 108.46M | 88.3M | 57.84M | 43.59M | 46.56M | 278.26M | 331.01M | 332.08M | 475.66M | 305.05M | 284.58M | 284.21M | 107.7M | 34.2M | 11.13M | 12.53M | 39.52M | 49.81M |
Net Cash Flow | -12.64M | -30.53M | -70.84M | -89.22M | -121.46M | 84.93M | 185.35M | 189.04M | 363.72M | 161.81M | 114.37M | 112.9M | -67.82M | -79.95M | -97.4M | -87.74M | -49.46M | -32.65M |
Free Cash Flow | -120.51M | -118.25M | -128.44M | -132.58M | -168.01M | -193.34M | -145.66M | -143.04M | -111.94M | -90.24M | -117.21M | -118M | -122.21M | -113.85M | -108.23M | -100.27M | -88.98M | -82.47M |